Elevated Circulating Platelet-Derived Microparticles in Patients with Active Inflammatory Bowel Disease
- 1 September 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 100 (9), 2042-2048
- https://doi.org/10.1111/j.1572-0241.2005.50381.x
Abstract
Platelet-derived microparticles (PDMPs) are active molecules involved in the hemostatic and inflammatory responses. To evaluate the changes in the platelet function in patients with inflammatory bowel disease (IBD), we measured circulating PDMP levels. Twenty-five healthy controls, 44 patients with ulcerative colitis (UC), and 43 patients with Crohn's Disease (CD) were studied. The PDMP and soluble P-selectin (sP-selectin) levels were measured by enzyme-linked immunosorbent assay (ELISA). In the healthy controls, the PDMP levels were 17.2 +/- 6.2 U/mL. Significant differences were not observed between the healthy controls and inactive UC patients (20.8 +/- 9.5 U/mL, n = 25) or between the healthy controls and inactive CD patients (17.6 +/- 7.8 U/mL, n = 24). In contrast, the PDMP levels were significantly higher in both active UC (49.2 +/- 33.6 U/mL, n = 19) and active CD (48.6 +/- 42.8 U/mL, n = 19) patients than in the healthy controls. A significant correlation was found between the PDMP levels and the clinical activity indexes (CAI) of UC patients (r = 0.65, p < 0.01, n = 44), and between the PDMP levels and Crohn's disease activity indexes (CDAI) (r = 0.72, p < 0.01, n = 43). Elevated PDMP levels in active patients were significantly reduced after remission. A significant correlation was observed between the PDMP levels and the sP-selectin levels (r = 0.60, p < 0.01, n = 122). Elevated circulating PDMPs in active IBD patients suggest a role for platelets in the pathogenesis of IBD.Keywords
This publication has 28 references indexed in Scilit:
- Measurement of soluble P‐selectin and soluble CD40 ligand in serum and plasmaJournal of Thrombosis and Haemostasis, 2004
- Platelets: signaling cells in the immune continuumTrends in Immunology, 2004
- Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamolePlatelets, 2004
- Serum‐Soluble Selectin Levels in Patients with Rheumatoid Arthritis and Systemic SclerosisScandinavian Journal of Immunology, 2004
- Platelet-Derived Microparticles in Patients with Arteriosclerosis ObliteransThrombosis Research, 2000
- Platelet factor 4 and β‐thromboglobulin in inflammatory bowel disease and giant cell arteritisEuropean Journal of Clinical Investigation, 2000
- Modulation of monocyte-endothelial cell interactions by platelet microparticles.JCI Insight, 1998
- Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.JCI Insight, 1997
- PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTIONThe Lancet, 1989
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989